<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epigenomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Epigenomics</journal-id>
<journal-id journal-id-type="publisher-id">EPI</journal-id>
<journal-title-group>
<journal-title>Epigenomics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1750-1911</issn>
<issn pub-type="epub">1750-192X</issn>
<publisher>
<publisher-name>Future Medicine Ltd</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29334242</article-id>
<article-id pub-id-type="pmc">5810842</article-id>
<article-id pub-id-type="doi">10.2217/epi-2017-0113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and disease in a dish: the epigenetics of neurodevelopmental disorders</article-title>
<alt-title alt-title-type="running-head">Lewis &amp; Kroll</alt-title>
<alt-title alt-title-type="running-head">The epigenetics of neurodevelopmental disorders</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Emily MA</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kroll</surname>
<given-names>Kristen L</given-names>
</name>
<xref ref-type="corresp" rid="C0001">*</xref>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<aff id="aff1">
<label>1</label>Department of Developmental Biology, Washington University School of Medicine, 660 S Euclid Avenue, Saint Louis, MO 63110, USA</aff>
</contrib-group>
<author-notes>
<corresp id="C0001">*Author for correspondence: Tel.: <phone>+1 314 362 7045</phone>; Fax: <fax>+1 314 362 7058</fax>; <email xlink:href="mailto:kkroll@wustl.edu">kkroll@wustl.edu</email></corresp>
<fn fn-type="COI-statement">
<p>
<bold>Financial &amp; competing interests disclosure</bold>
</p>
<p>This work was supported by grants to KL Kroll from the NIH (GM66815), the March of Dimes (#1-FY13–413), the American Epilepsy Society, the McDonnell Center for Cellular and Molecular Neurobiology at Washington University, and the Center for Regenerative Medicine at Washington University. This project was also supported by an NIGMS T32 training grant to EMA Lewis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.</p>
<p>No writing assistance was utilized in the production of this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>10</volume>
<issue>2</issue>
<fpage>219</fpage>
<lpage>231</lpage>
<history>
<date date-type="received">
<day>05</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Future Medicine Ltd</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="epi-10-219.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Human neurodevelopmental disorders (NDDs) involve mutations in hundreds of individual genes, with over-representation in genes encoding proteins that alter chromatin structure to modulate gene expression. Here, we highlight efforts to model these NDDs through <italic>in vitro</italic> differentiation of patient-specific induced pluripotent stem cells into neurons. We discuss how epigenetic regulation controls normal cortical development, how mutations in several classes of epigenetic regulators contribute to NDDs, and approaches for modeling cortical development and function using both directed differentiation and formation of cerebral organoids. We explore successful applications of these models to study both syndromic and nonsyndromic NDDs and to define convergent mechanisms, addressing both the potential and challenges of using this approach to define cellular and molecular mechanisms that underlie NDDs.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>autism spectrum disorder</kwd>
<kwd>cerebral cortex</kwd>
<kwd>cerebral organoid</kwd>
<kwd>chromatin</kwd>
<kwd>epigenetic</kwd>
<kwd>genetics</kwd>
<kwd>induced pluripotent stem cell</kwd>
<kwd><italic>in vitro</italic> differentiation</kwd>
<kwd>neurodevelopmental disorder</kwd>
<kwd>neuron</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>